WO2019009130A1 - ガラクトオリゴ糖の製造方法 - Google Patents
ガラクトオリゴ糖の製造方法 Download PDFInfo
- Publication number
- WO2019009130A1 WO2019009130A1 PCT/JP2018/024078 JP2018024078W WO2019009130A1 WO 2019009130 A1 WO2019009130 A1 WO 2019009130A1 JP 2018024078 W JP2018024078 W JP 2018024078W WO 2019009130 A1 WO2019009130 A1 WO 2019009130A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- galactosidase
- reaction
- galactooligosaccharides
- amount
- concentration
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
- C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/12—Disaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
Definitions
- the present invention relates to a method for producing galactooligosaccharides using ⁇ -galactosidase, more specifically, by causing ⁇ -galactosidase to act on a substrate in the presence of a specific metal ion at a predetermined concentration to obtain trisaccharides or more.
- the present invention relates to a method for improving the amount and reaction rate of galactooligosaccharides.
- ⁇ -galactosidase catalyzes galactosyl transfer as well as hydrolysis of ⁇ -D-galactoside bonds such as lactose, and produces galactooligosaccharides to selectively grow bifidobacteria in the intestine. Is used for
- Products obtained by galactosyl transfer reaction using ⁇ -galactosidase include trisaccharides such as ⁇ -D-galactopyranosyl (1-4) ⁇ -D-galactopyranosyl-D glucose (4'-GL)
- trisaccharides such as ⁇ -D-galactopyranosyl (1-6) -D-glucose
- trisaccharides are preferable from the viewpoint of improvement of the bifidobacteria growth promoting effect, etc.
- a technique to further increase the amount of galactooligosaccharides produced above. Further, from the viewpoint of reduction of production cost and improvement of production efficiency, it is important to shorten the reaction time until the production amount of galactooligosaccharide having three or more sugars becomes maximum, and a method for improving the reaction rate is desired ing.
- An object of the present invention is to provide a method for producing galactooligosaccharides using ⁇ -galactosidase, in which the amount and reaction rate of galactooligosaccharides having three or more saccharides are improved.
- the present inventors have found that by reacting ⁇ -galactosidase with a substrate in the presence of sodium and magnesium ions in a specific concentration range, trisaccharides or more can be obtained.
- the inventors have found that the production amount of galactooligosaccharide can be increased and the reaction time until the production amount reaches the maximum can be shortened, and the present invention has been completed.
- the present invention is a method for producing galactooligosaccharides characterized in that ⁇ -galactosidase is reacted with a substrate in the presence of 5 to 60 mM sodium ion and 0.5 to 8 mM magnesium ion.
- the production method of the present invention it is possible to increase the amount of production of galactooligosaccharides having three or more sugars, to improve the reaction rate, and to shorten the reaction time to reach the maximum amount of formation. . Therefore, galactooligosaccharides having three or more sugars can be efficiently produced at low cost.
- the method for producing galactooligosaccharide of the present invention is characterized in that ⁇ -galactosidase is reacted with a substrate in the presence of 5 to 60 mM sodium ion and 0.5 to 8 mM magnesium ion.
- the galactooligosaccharides include three or more galactooligosaccharides represented by the general formula Gal- (Gal) n-Glc (Gal is a galactose residue, Glc is glucose, and n is an integer of 1 to 6).
- ⁇ -galactosidase is an enzyme that catalyzes a reaction of hydrolyzing ⁇ -galactoside bonds such as lactose and o-nitrophenyl- ⁇ -D-galactopyranoside, and a galactosyl transfer reaction.
- the ⁇ -galactosidase used in the present invention is not particularly limited, but from the viewpoint of improvement in the amount of reaction and reaction rate of galactooligosaccharides having three or more sugars, genus Kluyveromyces, genus Streptococcus, and lactobacilli.
- Those derived from microorganisms belonging to the genus Lactobacillus, Bifidobacterium or Bacillus are preferably used, and more preferably Kluyveromyces lactis, Kluyveromyces fragilis, Streptococcus thermosis.
- Filth Streptococcus thermophilus
- Lacto Those derived from Lactobacillus bulgaricus and Bifidobacterium breve are preferred, and ⁇ -galactosidase derived from a microorganism belonging to the genus Kleberomyces is particularly preferred, and ⁇ -galactosidase derived from Kleberomyces is further preferred. .
- ⁇ -galactosidase for example, GODO-YNL (made by Joint Shusei Co., Ltd.), maxilacto LG 5000 (made by DSM) from Kluyveromyces lactis, Lactozyme 3000 L from Kluyveromyces fragilis, etc. (Manufactured by Novozymes), Lactase Y-ST (manufactured by Yakult Pharmaceutical Co., Ltd.) derived from Streptococcus thermophilus, and the like can be mentioned.
- GODO-YNL made by Joint Shusei Co., Ltd.
- maxilacto LG 5000 made by DSM
- Lactozyme 3000 L from Kluyveromyces fragilis
- Lactase Y-ST manufactured by Yakult Pharmaceutical Co., Ltd.
- the form of the microorganism having ⁇ -galactosidase activity or the form of ⁇ -galactosidase derived from the microorganism is not particularly limited.
- a microorganism having ⁇ -galactosidase activity when using a microorganism having ⁇ -galactosidase activity, it is cultured according to a known culture method of a microorganism, and the obtained culture solution is used as it is or, if necessary, known centrifugation, membrane treatment, drying, crushing, etc.
- the solution is subjected to the treatment of (1) and used as a cell concentrate or pellet, a dried cell, a cell lysate or the like.
- the cells may be viable cells, or may be treated with an organic solvent, freeze-dried or the like to make them dead.
- ⁇ -galactosidase derived from a microorganism having ⁇ -galactosidase activity purification conditions and the degree of purification are not particularly limited, and general purification techniques can be used. After culturing the microorganism according to a known method, the cells are separated by separation means such as centrifugation and membrane treatment, and if the culture supernatant contains ⁇ -galactosidase, this is collected and the crude enzyme solution can do. When ⁇ -galactosidase is contained in the cells, the extract is obtained physically by disrupting the cells with a homogenizer or sonication, or enzymatically treating the cells with a cell wall lytic enzyme or the like.
- Crude solutions may be combined as appropriate by combining ammonium sulfate precipitation treatment, dialysis, gel filtration chromatography, ion exchange chromatography, adsorption chromatography, affinity chromatography and the like to obtain a highly purified purified enzyme solution.
- the substrate on which the above-mentioned ⁇ -galactosidase is caused to act there are cases where it is a single substrate acting as both an acceptor and a donor of galactosyl group, and when an acceptor and a donor of galactosyl group separately coexist. included.
- a substrate serving as a donor of a galactosyl group include lactose, o-nitrophenyl- ⁇ -D-galactopyranoside and the like.
- a substrate serving as a galactosyl group acceptor lactose, galactooligosaccharide, glucose, glycerol and the like can be mentioned.
- the concentration of the substrate is appropriately set according to the type and the like, but when using lactose, for example, the concentration is 5 to 65% by mass from the viewpoint of the effect of improving the formation amount and formation rate of galactooligosaccharides of three or more sugars. It is preferably present, and more preferably 15 to 60% by mass.
- the amount of ⁇ -galactosidase added can be appropriately adjusted according to the desired reaction time, but is preferably 10 to 1000 U, more preferably 30 to 800 U, per gram of lactose.
- the reaction temperature and the like can be appropriately set in accordance with the optimum temperature and the like of ⁇ -galactosidase to be used. For example, when ⁇ -galactosidase derived from C.
- the reaction temperature is preferably 30 to 50 ° C., and more preferably 40 to 50 ° C.
- the measurement of the enzyme activity (U) is as follows. [Method for measuring ⁇ -galactosidase enzyme activity (U)] 0.5 mL of diluted enzyme sample was taken in a test tube, and 100 mM KH 2 PO 4 -NaOH buffer solution (pH 6.5, hereinafter referred to as “buffer”) to which manganese chloride was added to be 0.1 mM Is added and mixed, and then incubated at 37 ° C. for 3 minutes.
- buffer 100 mM KH 2 PO 4 -NaOH buffer solution
- the above-mentioned ⁇ -galactosidase is reacted with a substrate in the presence of sodium ion and magnesium ion.
- concentration of sodium ion in the reaction system is 5 to 60 mM.
- concentration of magnesium ion is 0.5 to 8 mM, more preferably 1.5 to 8 mM.
- sodium ions and magnesium ions can be added to the reaction system in the form of a solid or buffer solution such as chlorides, carbonates, acetates, phosphates and the like, and from the point of little change in pH after addition, chloride Sodium and magnesium chloride are preferred.
- the galactosyl transfer reaction by ⁇ -galactosidase is in competition with the substrate hydrolysis reaction. Therefore, when ⁇ -galactosidase is allowed to act on the substrate, the desired galactooligosaccharide is produced, and glucose and galactose are produced by the competing hydrolysis reaction. Such monosaccharides are produced, and once produced, galactooligosaccharides are also hydrolyzed.
- the galactosyl transfer reaction between a specific donor and an acceptor It is difficult to control to produce the desired galactooligosaccharides.
- the galactosyl transfer reaction between a specific donor and an acceptor It is difficult to control to produce the desired galactooligosaccharides.
- the amount of galactooligosaccharides of, among others, galactooligosaccharides is increased. Further, since the reaction rate can be further increased to shorten the time to reach the maximum production amount, galactooligosaccharides having three or more sugars can be efficiently produced at low cost.
- the method of the present invention is also applicable to secondary reactions in the preparation of galactooligosaccharides by sequential reactions in which two ⁇ -galactosidases are allowed to act. That is, after reacting a microorganism having ⁇ -galactosidase activity or ⁇ -galactosidase derived from the microorganism with a substrate as a primary reaction, 5 to 60 mM of ⁇ -galactosidase different from that used in the primary reaction is used as a secondary reaction.
- the primary reaction solution in the presence of sodium ions of 0.5 to 8 mM and magnesium ions of 0.5 to 8 mM, the amount of unreacted substrate can be decreased and the amount of galactooligosaccharides can be increased.
- microorganism having ⁇ -galactosidase activity used in the primary reaction for example, microorganisms belonging to Sporobolomyces (Sporobolomyces), Aspergillus (Aspergillus), and Bacillus (Bacillus) are preferable, and in particular, the genus belongs to Sporoboromyces. Microorganisms are preferred, and Sporobolomyces singularis is more preferred from the viewpoint of improvement in the amount and reaction rate of galactooligosaccharides having three or more sugars.
- the form of the microorganism having ⁇ -galactosidase activity or the form of ⁇ -galactosidase derived from the microorganism used in the primary reaction is not particularly limited, and, for example, culture fluid, bacterial cells obtained by concentrating the culture fluid by centrifugation, membrane treatment, etc. Concentrates or pellets, dried cells, disrupted cells, crude enzyme solution, purified enzyme solution, enzyme powder and the like can be mentioned, and these are prepared according to known methods.
- a microorganism having ⁇ -galactosidase activity when using a microorganism having ⁇ -galactosidase activity, it is cultured according to a known culture method of a microorganism, and the obtained culture solution is used as it is or, if necessary, known centrifugation, membrane treatment, drying, crushing, etc.
- the solution is subjected to the treatment of (1) and used as a cell concentrate or pellet, a dried cell, a cell lysate or the like.
- the cells may be viable cells, or may be treated with an organic solvent, freeze-dried or the like to make them dead.
- ⁇ -galactosidase derived from a microorganism having ⁇ -galactosidase activity purification conditions and the degree of purification are not particularly limited, and general purification techniques can be used. After culturing the microorganism according to a known method, the cells are separated by separation means such as centrifugation and membrane treatment, and if the culture supernatant contains ⁇ -galactosidase, this is collected and the crude enzyme solution can do. When ⁇ -galactosidase is contained in the cells, the extract is obtained physically by disrupting the cells with a homogenizer or sonication, or enzymatically treating the cells with a cell wall lytic enzyme or the like.
- Crude solutions may be combined as appropriate by combining ammonium sulfate precipitation treatment, dialysis, gel filtration chromatography, ion exchange chromatography, adsorption chromatography, affinity chromatography and the like to obtain a highly purified purified enzyme solution.
- the microorganism having the above-mentioned ⁇ -galactosidase activity or ⁇ -galactosidase derived from the microorganism is reacted with a substrate such as lactose.
- the reaction conditions can be appropriately set according to the properties of the microorganism having ⁇ -galactosidase activity to be used or the ⁇ -galactosidase derived from the microorganism. For example, when S.
- the concentration of lactose is 10 to 60 mass in terms of the effect of improving the amount and rate of formation of galactooligosaccharides. % Is preferable, and 40 to 50% by mass is more preferable.
- the amount of Sporobolomyces cyngularis added is preferably 0.03 to 0.3 U, and more preferably 0.2 to 0.3 U per 1 g of lactose.
- the reaction temperature is about 30 to 70 ° C., and the reaction may be performed for about 24 to 96 hours.
- the primary reaction solution obtained in the primary reaction is reacted with ⁇ -galactosidase different from that used in the primary reaction in the presence of sodium ions and magnesium ions in a specific concentration range.
- the ⁇ -galactosidase used in the secondary reaction is not particularly limited, but from the viewpoint of improving the amount of reaction and the reaction rate of galactooligosaccharides having three or more sugars, the genus Kluyveromyces, Streptococcus, Those derived from a microorganism belonging to the genus Lactobacillus, Bifidobacterium or Bacillus are preferably used, and more preferably Kluyveromyces lactis, Kluyveromyces fragilis, Streptococcus Thermophilus (Streptococcus thermophilus), Those derived from Lactobacillus bulgaricus and Bifidobacterium breve are preferred, and ⁇ -galactosidase derived from a microorganism belonging to the genus Kleberomyces is particularly preferred, and ⁇ -galactosidase derived from Kleberomyces is further preferred. .
- the concentration of sodium ion in the secondary reaction solution is 5 to 60 mM.
- the concentration of magnesium ion is 0.5 to 8 mM, more preferably 1.5 to 8 mM.
- the load for desalting and purifying galactooligosaccharides becomes large, which is not preferable.
- the presence of sodium ions and magnesium ions in such a concentration range can improve the production amount and production efficiency of galactooligosaccharides.
- Sodium ions and magnesium ions can be added to the reaction system in the form of solid or buffer solutions such as chlorides, carbonates, acetates, phosphates and the like, and from the point of little change in pH after addition, chloride Sodium and magnesium chloride are preferred.
- the concentration of residual lactose in the primary reaction solution is preferably 5 to 65% by mass, and more preferably 15 to 60% by mass, from the viewpoint of the improvement in the amount of galactooligosaccharides having three or more sugars and the reaction rate.
- the amount of ⁇ -galactosidase added is preferably 10 to 1000 U, more preferably 30 to 800 U, per gram of remaining lactose.
- the reaction temperature and the like can be appropriately set in accordance with the optimum temperature and the like of ⁇ -galactosidase to be used. For example, when .beta.-galactosidase derived from C. lactis is used, the reaction temperature is preferably 30 to 50.degree. C., and more preferably 40 to 50.degree. C., from the viewpoint of the improvement of the amount and rate of formation of galactooligosaccharides of three or more sugars. .
- the reaction solution in which the galactooligosaccharide is produced as described above is used as it is or is appropriately decolorized with activated carbon, filtered with diatomaceous earth, desalted with ion exchange resin, concentrated with a concentrator, or as a liquid sugar, or a spray drier
- it can be used as it is as table sugar, or it can be added to food and drink such as fermented milk, lactic acid bacteria drink, bread, jam and confectionery.
- the addition concentration at that time and it may be appropriately determined in consideration of flavor, physical properties and the like.
- it can be used for cosmetics, medicines and the like.
- Example 1 15 g of local grade lactose was weighed into a 100 mL Erlenmeyer flask, and 85 g of Bis-Tris buffer solution (pH 6.8) prepared with deionized water (containing neither sodium ion nor magnesium ion) was added (lactose concentration 15%). After completely dissolving lactose in a boiling water bath, it was cooled in a 45 ° C. constant temperature water bath.
- Bis-Tris buffer solution pH 6.8
- deionized water containing neither sodium ion nor magnesium ion
- Example 2 The ratio of the residual disaccharide and the galactooligosaccharide having three or more saccharides was measured in the same manner as in Example 1 except that 2.6 M sodium chloride was added so that the sodium ion concentration would be 30 mM. The results are shown in Table 2.
- Example 3 The experiment was conducted except that the lactose concentration in the reaction solution was 45%, 2.6 M sodium chloride was added so that the sodium ion concentration was 5 mM, and GODO-YNL was reacted at 45 ° C. by adding 250 U per 1 g of lactose.
- the ratio of residual disaccharides to galactooligosaccharides having 3 or more saccharides was measured. The results are shown in Table 3.
- Example 4 The experiment was conducted except that the lactose concentration in the reaction solution was 45%, 2.6 M sodium chloride was added so that the sodium ion concentration was 60 mM, and GODO-YNL was reacted at 45 ° C. by adding 250 U per 1 g of lactose.
- the ratio of residual disaccharides to galactooligosaccharides having 3 or more saccharides was measured. The results are shown in Table 4.
- the amount of galactooligosaccharides having three or more sugars can be increased in a short reaction time, it is useful as an industrial method for producing galactooligosaccharides.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
[β-ガラクトシダーゼ酵素活性(U)の測定法]
希釈酵素試料0.5mLを試験管に取り、0.1mMとなるように塩化マンガンを加えた100mMのKH2PO4-NaOH緩衝液(pH6.5、以下、「緩衝液」という)0.5mLを加えて混合した後、37℃で3分間保温する。あらかじめ37℃で保温しておいた0.1%のo-ニトロフェニル-β-D-ガラクトピラノシド(以下、「ONPG」という)溶液1.0mLを加えてすばやく混合し、正確に37℃で1分間保温する。0.2Mの炭酸ナトリウム溶液2.0mLを加えてすばやく混合し、反応を停止する(試験系)。別に、希釈酵素試料0.5mLを試験管に取り、緩衝液0.5mLを加えて混合した後、0.2Mの炭酸ナトリウム溶液2.0mLを加え、37℃で3分間保温し、あらかじめ37℃で保温しておいたONPG溶液0.1mLを加えて混合し、正確に37℃で1分間保温する(盲検系)。蒸留水を対照として試験系および盲検系の420nmの吸光度を測定し、次式により酵素活性(U)を算出した。
[数式1]
酵素活性*=(A1-A2)×10×B
A1:試験系の吸光度
A2:盲検系の吸光度
B :希釈倍率
* U/ml
100mL容三角フラスコに局方グレードの乳糖を15g秤量し、脱イオン水で調製した(ナトリウムイオンとマグネシウムイオンが含まれていない)Bis-Tris緩衝液(pH6.8)を85g加えた(乳糖濃度15%)。沸騰水浴中で乳糖を完全に溶解した後に、45℃の恒温水槽中で冷却した。これに2.6Mの塩化ナトリウムをナトリウムイオン濃度が15mMとなるように加え、また0.75Mの塩化マグネシウムをマグネシウムイオン濃度が下記表1に記載された濃度になるように加え、これらにGODO-YNL(クリベロマイセス・ラクチス由来のβ―ガラクトシダーゼ、合同酒精株式会社製)を乳糖1g当たり600U添加して40℃で反応させた。これら反応液を経時的に7時間目までサンプリングし、沸騰水浴中で90℃まで昇温して酵素を失活させた後、残2糖と3糖以上のガラクトオリゴ糖の割合を下記条件に基づくHPLC分析により測定した。各マグネシウムイオン濃度における3糖以上のガラクトオリゴ糖の生成量が最大となったときの測定結果を表1に示す。なお、残2糖には未反応の乳糖及び転移2糖が含まれる。
カラム:Shodex SUGAR KS-802
移動層:精製水
流 速:0.5mL/min
検 出:示差屈折計
2.6Mの塩化ナトリウムをナトリウムイオン濃度が30mMとなるように添加した以外は実施例1と同様にして残2糖と3糖以上のガラクトオリゴ糖の割合を測定した。結果を表2に示す。
反応液中の乳糖濃度を45%とし、2.6Mの塩化ナトリウムをナトリウムイオン濃度が5mMとなるように添加し、GODO-YNLを乳糖1g当たり250U添加して45℃で反応させた以外は実施例1と同様にして残2糖と3糖以上のガラクトオリゴ糖の割合を測定した。結果を表3に示す。
反応液中の乳糖濃度を45%とし、2.6Mの塩化ナトリウムをナトリウムイオン濃度が60mMとなるように添加し、GODO-YNLを乳糖1g当たり250U添加して45℃で反応させた以外は実施例1と同様にして残2糖と3糖以上のガラクトオリゴ糖の割合を測定した。結果を表4に示す。
Claims (3)
- 5~60mMのナトリウムイオン及び0.5~8mMのマグネシウムイオンの存在下で、β-ガラクトシダーゼを基質と反応させることを特徴とするガラクトオリゴ糖の製造方法。
- マグネシウムイオンの濃度が1.5~8mMである請求項1記載の製造方法。
- β-ガラクトシダーゼが、クリベロマイセス属に属する微生物由来のものである請求項1又は2記載の製造方法。
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019527643A JPWO2019009130A1 (ja) | 2017-07-04 | 2018-06-26 | ガラクトオリゴ糖の製造方法 |
US16/628,163 US20210010045A1 (en) | 2017-07-04 | 2018-06-26 | Method for producing galactooligosaccharide |
AU2018295686A AU2018295686B2 (en) | 2017-07-04 | 2018-06-26 | Method for producing galactooligosaccharide |
KR1020207003135A KR20200026274A (ko) | 2017-07-04 | 2018-06-26 | 갈락토올리고당의 제조 방법 |
CN201880044393.2A CN110914444A (zh) | 2017-07-04 | 2018-06-26 | 低聚半乳糖的制造方法 |
EP18828415.2A EP3650550A4 (en) | 2017-07-04 | 2018-06-26 | PROCESS FOR THE PRODUCTION OF GALACTOOLIGOSACCHARIDE |
SG11202000020RA SG11202000020RA (en) | 2017-07-04 | 2018-06-26 | Method for producing galactooligosaccharide |
US17/559,121 US11718841B2 (en) | 2017-07-04 | 2021-12-22 | Method for producing galactooligosaccharide |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017-130761 | 2017-07-04 | ||
JP2017130761 | 2017-07-04 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/628,163 A-371-Of-International US20210010045A1 (en) | 2017-07-04 | 2018-06-26 | Method for producing galactooligosaccharide |
US17/559,121 Division US11718841B2 (en) | 2017-07-04 | 2021-12-22 | Method for producing galactooligosaccharide |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019009130A1 true WO2019009130A1 (ja) | 2019-01-10 |
Family
ID=64950827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2018/024078 WO2019009130A1 (ja) | 2017-07-04 | 2018-06-26 | ガラクトオリゴ糖の製造方法 |
Country Status (9)
Country | Link |
---|---|
US (2) | US20210010045A1 (ja) |
EP (1) | EP3650550A4 (ja) |
JP (2) | JPWO2019009130A1 (ja) |
KR (1) | KR20200026274A (ja) |
CN (1) | CN110914444A (ja) |
AU (1) | AU2018295686B2 (ja) |
SG (1) | SG11202000020RA (ja) |
TW (1) | TWI784019B (ja) |
WO (1) | WO2019009130A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021100595A1 (ja) * | 2019-11-22 | 2021-05-27 | 東邦チタニウム株式会社 | 銅粉体とその製造方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4101301A1 (de) * | 2021-06-08 | 2022-12-14 | DMK Deutsches Milchkontor GmbH | Verfahren zur herstellung von galactooligosacchariden |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6279791A (ja) * | 1985-10-02 | 1987-04-13 | Snow Brand Milk Prod Co Ltd | ラクト−ス資化性菌を利用した6’−ガラクトシルラクト−スの製造法 |
JPH0522517B2 (ja) | 1986-10-27 | 1993-03-29 | Yakult Honsha Kk | |
JP2001245690A (ja) * | 2000-03-03 | 2001-09-11 | Yakult Honsha Co Ltd | グリコシドまたはオリゴ糖の製造方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03151875A (ja) * | 1989-11-10 | 1991-06-28 | Yakult Honsha Co Ltd | β―ガラクトシダーゼの安定化法 |
JPH0522517A (ja) | 1991-07-09 | 1993-01-29 | Fuji Xerox Co Ltd | 密着型イメージセンサ |
KR100945306B1 (ko) * | 2007-12-31 | 2010-03-03 | 주식회사 삼양제넥스 | 고순도 갈락토올리고당의 제조방법 |
CN105274166B (zh) | 2015-12-04 | 2018-09-11 | 南京林业大学 | 一种低聚半乳糖联产l-乳酸的方法 |
EP3402892A4 (en) * | 2016-01-12 | 2018-11-21 | Vitalus Nutrition Inc. | Method for producing galactooligosaccharides from lactose |
RU2622078C1 (ru) * | 2016-01-12 | 2017-06-09 | федеральное государственное автономное образовательное учреждение высшего образования "Северо-Кавказский федеральный университет" | Способ получения комбинированного ферментного препарата бета-галактозидаз |
-
2018
- 2018-06-26 WO PCT/JP2018/024078 patent/WO2019009130A1/ja unknown
- 2018-06-26 SG SG11202000020RA patent/SG11202000020RA/en unknown
- 2018-06-26 EP EP18828415.2A patent/EP3650550A4/en active Pending
- 2018-06-26 AU AU2018295686A patent/AU2018295686B2/en active Active
- 2018-06-26 KR KR1020207003135A patent/KR20200026274A/ko not_active Application Discontinuation
- 2018-06-26 CN CN201880044393.2A patent/CN110914444A/zh active Pending
- 2018-06-26 JP JP2019527643A patent/JPWO2019009130A1/ja active Pending
- 2018-06-26 US US16/628,163 patent/US20210010045A1/en not_active Abandoned
- 2018-06-29 TW TW107122438A patent/TWI784019B/zh active
-
2021
- 2021-12-22 US US17/559,121 patent/US11718841B2/en active Active
-
2023
- 2023-04-14 JP JP2023066479A patent/JP2023093593A/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6279791A (ja) * | 1985-10-02 | 1987-04-13 | Snow Brand Milk Prod Co Ltd | ラクト−ス資化性菌を利用した6’−ガラクトシルラクト−スの製造法 |
JPH0522517B2 (ja) | 1986-10-27 | 1993-03-29 | Yakult Honsha Kk | |
JP2001245690A (ja) * | 2000-03-03 | 2001-09-11 | Yakult Honsha Co Ltd | グリコシドまたはオリゴ糖の製造方法 |
Non-Patent Citations (2)
Title |
---|
MONTILLA, ANTONIA ET AL.: "Effects of monovalent cations (Na+ and K+) on galactooligosaccharides production during lactose hydrolysis by Kluyveromyces lactis beta -galactosidase", MICHWISSENSCHAFT, vol. 67, 2012, pages 1 - 9, XP055661854, ISSN: 0026-3788 * |
See also references of EP3650550A4 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021100595A1 (ja) * | 2019-11-22 | 2021-05-27 | 東邦チタニウム株式会社 | 銅粉体とその製造方法 |
Also Published As
Publication number | Publication date |
---|---|
JP2023093593A (ja) | 2023-07-04 |
US20220112533A1 (en) | 2022-04-14 |
EP3650550A1 (en) | 2020-05-13 |
US20210010045A1 (en) | 2021-01-14 |
US11718841B2 (en) | 2023-08-08 |
KR20200026274A (ko) | 2020-03-10 |
CN110914444A (zh) | 2020-03-24 |
TWI784019B (zh) | 2022-11-21 |
TW201907011A (zh) | 2019-02-16 |
JPWO2019009130A1 (ja) | 2020-05-07 |
AU2018295686A1 (en) | 2020-02-06 |
AU2018295686B2 (en) | 2023-12-21 |
EP3650550A4 (en) | 2021-04-07 |
SG11202000020RA (en) | 2020-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6105680B2 (ja) | 超高純度ガラクトオリゴ糖を製造する方法 | |
Jayamuthunagai et al. | D-Tagatose production by permeabilized and immobilized Lactobacillus plantarum using whey permeate | |
Adamczak et al. | Influence of reaction medium composition on enzymatic synthesis of galactooligosaccharides and lactulose from lactose concentrates prepared from whey permeate | |
KR101399712B1 (ko) | 신규 유발효물 및 그의 이용 | |
JPH01168234A (ja) | ガラクトオリゴ糖含有加工乳の製造法 | |
JP2009514543A (ja) | オリゴ糖の製造方法 | |
JP2023093593A (ja) | ガラクトオリゴ糖の製造方法 | |
Saburi et al. | Practical preparation of epilactose produced with cellobiose 2-epimerase from Ruminococcus albus NE1 | |
Yañez-Ñeco et al. | Synthesis of β (1→ 3) and β (1→ 6) galactooligosaccharides from lactose and whey using a recombinant β-galactosidase from Pantoea anthophila | |
WO2019194062A1 (ja) | Paenibacillus pabuli由来のガラクトオリゴ糖を製造可能な酵素、およびガラクトオリゴ糖を製造する方法 | |
Chen et al. | Construction of an enzymatic route using a food-grade recombinant Bacillus subtilis for the production and purification of epilactose from lactose | |
JPH0522516B2 (ja) | ||
KR20140012932A (ko) | 유산균 추출물 및 유청을 이용한 갈락토올리고당의 제조방법 | |
C Perotti et al. | Dairy products modified in their lactose content | |
Pruksasri et al. | Purification of heterooligosaccharides by microbial treatment and nanofiltration | |
RU2622078C1 (ru) | Способ получения комбинированного ферментного препарата бета-галактозидаз | |
Deshmukh et al. | Waste to nutrition: The evolution of whey, a byproduct to galactooligosaccharides production | |
JP6067800B2 (ja) | 微生物の死菌化方法 | |
JP2000041693A (ja) | ガラクトオリゴ糖の製造方法 | |
Jung et al. | Production and application of galacto-oligosaccharides from lactose by a recombinant β-galactosidase of Bifidobacterium infantis overproduced by Pichia pastoris | |
Zhao et al. | Preparation of sweet milk and yogurt containing d-tagatose by the l-arabinose isomerase derived from Lactobacillus rhamnosus | |
KR101342791B1 (ko) | 1,4-디히드록시-2-나프토산 생산능을 가지는 락토바실러스 카제이 lp1 균주 및 이의 이용 | |
CN115804408A (zh) | 一种低糖甜酸奶的制备方法 | |
KR20150040842A (ko) | 유산균 추출물 및 유청을 이용한 갈락토올리고당의 제조방법 | |
KR20130083174A (ko) | 유산균 추출물 및 유청을 이용한 갈락토올리고당의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18828415 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2019527643 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20207003135 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2018295686 Country of ref document: AU Date of ref document: 20180626 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2018828415 Country of ref document: EP Effective date: 20200204 |